Persistent inflammation and its relationship to leptin and insulin in phases of bipolar disorder from acute depression to full remission. (11th August 2014)

• Record Type: Journal Article
• Authors: Tsai, Shang‐Ying; Chung, Kuo‐Hsuan; Huang, Shou‐Hung; Chen, Pao‐Huan; Lee, Hsin‐Chien; Kuo, Chian‐Jue
• Is Part Of: Bipolar disorders. Volume 16:Number 8(2014)
• Page Start: 800
• Page End: 808
• Publication Date: 2014-08-11
• Subjects: Manic-depressive illness -- Periodicals; Depression, Mental -- Periodicals; 616.895
• DOI: 10.1111/bdi.12240
• Languages: English
• ISSNs: 1398-5647

Abstract

<abstract abstract-type="main" id="bdi12240-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="bdi12240-sec-0001" sec-type="section"> <title>Objective</title> <p>A proinflammatory phase with various immunomodulatory mechanisms has been noted in bipolar mania and major depression. Weight gain and increased production of leptin may be associated with immunomodulation and insulin resistance in bipolar disorder. However, immunomodulation and its linkage with leptin and insulin in the depressive episode of bipolar disorder remain unclear. We investigated alterations in inflammatory markers and their relationship with leptin and insulin levels in patients with phases of bipolar disorder from acute depression to full remission.</p> </sec> <sec id="bdi12240-sec-0002" sec-type="section"> <title>Methods</title> <p>Thirty‐two physically healthy bipolar I depressed patients aged <45 years and age‐ and sex‐matched healthy controls participated in this study. We measured their circulating levels of leptin, insulin, high‐sensitivity C‐reactive protein (hs‐CRP), soluble interleukin‐2 receptor (sIL‐2R), soluble interleukin‐6 receptor (sIL‐6R), soluble tumor necrosis factor receptor 1 (sTNF‐R1), and interleukin‐1 receptor antagonist (IL‐1Ra) in three phases, i.e., acute depression, subsequent partial remission, and full remission.</p> </sec> <sec id="bdi12240-sec-0003" sec-type="section"> <title>Results</title> <p>In acute depression, subsequent partial remission, and full remission, patients with bipolar disorder had significantly higher mean levels of hs‐CRP, IL‐1Ra, sTNF‐R1, and sIL‐2R compared with control subjects. The IL‐1Ra and sTNF‐R1 levels in various affective phases were significantly correlated to body mass index, leptin level, circulating lipids, and medication status. The sIL‐2R levels in the three affective phases were all independent of other inflammatory markers and clinical and laboratory variables. Patients showed no alteration of sIL‐6R levels through the depressive episode.</p> </sec> <sec id="bdi12240-sec-0004" sec-type="section"> <title>Conclusions</title> <p>Patients with bipolar disorder in depressive episodes may exhibit persistent inflammation with elevated levels of hs‐CRP, IL‐1Ra, sTNF‐R1, and sIL‐2R but not sIL‐6R from the acute phases to full remission. Only sIL‐2R production seems to be tightly linked with the pathophysiology of bipolar depression and is independent of insulin and leptin levels.</p> </sec> </abstract>